Blastic plasmacytoid dendritic cell neoplasm (BPDCN) and mature plasmacytoid dendritic cell proliferation (MPDCP): the same cell of origin from a clonal haematopoiesis of indeterminate potential (CHIP)?
Margherita Vannucchi
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorMaria Chiara Siciliano
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorMassimo Granai
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorDomenico Ferrara
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorRoberto Boccacci
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorCosimo Lori
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorDanilo Tarantino
SOD Ematologia, Università di Firenze, AOU Careggi, Firenze, Italy
Search for more papers by this authorLeonardo Signori
CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
Search for more papers by this authorPaola Guglielmelli
CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
Search for more papers by this authorCorresponding Author
Lorenzo Leoncini
Department of Medical Biotechnology, University of Siena, Siena, Italy
Address for correspondence: L Leoncini, Department of Medical Biotechnology, University of Siena, Siena, Italy. e-mail: [email protected]
Search for more papers by this authorStefano Lazzi
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorMargherita Vannucchi
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorMaria Chiara Siciliano
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorMassimo Granai
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorDomenico Ferrara
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorRoberto Boccacci
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorCosimo Lori
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this authorDanilo Tarantino
SOD Ematologia, Università di Firenze, AOU Careggi, Firenze, Italy
Search for more papers by this authorLeonardo Signori
CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
Search for more papers by this authorPaola Guglielmelli
CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
Search for more papers by this authorCorresponding Author
Lorenzo Leoncini
Department of Medical Biotechnology, University of Siena, Siena, Italy
Address for correspondence: L Leoncini, Department of Medical Biotechnology, University of Siena, Siena, Italy. e-mail: [email protected]
Search for more papers by this authorStefano Lazzi
Department of Medical Biotechnology, University of Siena, Siena, Italy
Search for more papers by this author
Open Research
Data availability statement
The data that support the findings of this study are openly available upon request.
References
- 1Gong X, Li C, Wang Y et al. Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells. Blood Sci. 2022; 4; 38–43.
- 2Yamada T, Hiramoto N, Mori T et al. Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal haematopoiesis. Blood Cancer J. 2023; 13; 119.
- 3Suma S, Sakata-Yanagimoto M, Nguyen TB et al. Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis. Int. J. Hematol. 2018; 108; 447–451.
- 4Allman D, Dalod M, Asselin-Paturel C et al. Ikaros is required for plasmacytoid dendritic cell differentiation. Blood 2006; 108; 4025–4034.
- 5Welner RS, Bararia D, Amabile G et al. C/EBPα is required for development of dendritic cell progenitors. Blood 2013; 121; 4073–4081.
- 6Bisig B, Savage KJ, De Leval L. Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions. Haematologica 2023; 108; 3227–3243.
Online Version of Record before inclusion in an issue
